SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-010055
Filing Date
2020-08-10
Accepted
2020-08-10 08:22:08
Documents
55
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ruby-20200630x10q.htm   iXBRL 10-Q 1924730
2 EX-10.1 ruby-20200630xex10d1.htm EX-10.1 74225
3 EX-31.1 ruby-20200630xex31d1.htm EX-31.1 12033
4 EX-31.2 ruby-20200630xex31d2.htm EX-31.2 12847
5 EX-32.1 ruby-20200630xex32d1.htm EX-32.1 7199
6 EX-32.2 ruby-20200630xex32d2.htm EX-32.2 7180
  Complete submission text file 0001558370-20-010055.txt   5544664

Data Files

Seq Description Document Type Size
7 EX-101.SCH ruby-20200630.xsd EX-101.SCH 32094
8 EX-101.CAL ruby-20200630_cal.xml EX-101.CAL 41089
9 EX-101.DEF ruby-20200630_def.xml EX-101.DEF 90896
10 EX-101.LAB ruby-20200630_lab.xml EX-101.LAB 324844
11 EX-101.PRE ruby-20200630_pre.xml EX-101.PRE 218360
12 EXTRACTED XBRL INSTANCE DOCUMENT ruby-20200630x10q_htm.xml XML 760211
Mailing Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139 617-679-9600
Rubius Therapeutics, Inc. (Filer) CIK: 0001709401 (see all company filings)

IRS No.: 042688109 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38586 | Film No.: 201087223
SIC: 2836 Biological Products, (No Diagnostic Substances)